These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28476123)

  • 1. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
    Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
    Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
    J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
    Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
    BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER.
    Gilligan LC; Rahman HP; Hewitt AM; Sitch AJ; Gondal A; Arvaniti A; Taylor AE; Read ML; Morton DG; Foster PA
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4435-4447. PubMed ID: 28945888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
    Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
    Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
    Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-β/NF-κB Signals.
    Zhu G; Huang Y; Wu C; Wei D; Shi Y
    DNA Cell Biol; 2016 Aug; 35(8):434-42. PubMed ID: 27082459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
    Chimento A; Sirianni R; Casaburi I; Zolea F; Rizza P; Avena P; Malivindi R; De Luca A; Campana C; Martire E; Domanico F; Fallo F; Carpinelli G; Cerquetti L; Amendola D; Stigliano A; Pezzi V
    Oncotarget; 2015 Aug; 6(22):19190-203. PubMed ID: 26131713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
    Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis.
    Jacenik D; Beswick EJ; Krajewska WM; Prossnitz ER
    World J Gastroenterol; 2019 Aug; 25(30):4092-4104. PubMed ID: 31435166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
    Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q
    Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells.
    Vo DH; Hartig R; Weinert S; Haybaeck J; Nass N
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31540491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled estrogen receptor 1 (GPER 1) mediates estrogen-induced, proliferation of leiomyoma cells.
    Jiang X; Ye X; Ma J; Li W; Wu R; Jun L
    Gynecol Endocrinol; 2015; 31(11):894-8. PubMed ID: 26416628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
    Xiang S; Xiang T; Xiao Q; Li Y; Shao B; Luo T
    Int J Oncol; 2017 Sep; 51(3):801-811. PubMed ID: 28677721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells.
    Zhu P; Liao LY; Zhao TT; Mo XM; Chen GG; Liu ZM
    Mol Cell Endocrinol; 2017 Feb; 442():68-80. PubMed ID: 27940299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.